I just don't look for results until the end of the trial. If we hear anything early I'll simply be pleasantly surprised. ;)
Btw, I was just reading and posting in the comment section of the most recent SA article on ATHX. I can't believe how unrealistic and misinformed some of those commenters are. I was glad to see you educate a few. Especially the one discussing phase III trials and how they won't be checking for efficacy. How can anyone come to that belief? So glad you set her straight. lol
In Reply to 'Seel'
I'm with ya on estimates. I'm hoping for a realistic 14 within a year and 20 by end of 2015. The ph1/2 stroke trial hasn't finished recruiting yet but the trial still could be finished by Sept 2015, as the company estimates. If they're close to being accurate in that estimation and they are able to finish the trial in q4 2015, we'll have results maybe late q1,16...If results are good - we're good. Better than good.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM